{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:17:29Z","timestamp":1758266249701,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.transproceed.2024.03.042","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T04:04:56Z","timestamp":1720929896000},"page":"1513-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney Transplantation"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-4479","authenticated-orcid":false,"given":"Napat","family":"Leeaphorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose Mary","family":"Attieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani M.","family":"Wadei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shennen A.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surakit","family":"Pungpapong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcin","family":"Taner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wisit","family":"Cheungpasitporn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tambi","family":"Jarmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4 Suppl. 1","key":"10.1016\/j.transproceed.2024.03.042_bib0001","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US renal data system 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.transproceed.2024.03.042_bib0002","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1993.03510110079036","article-title":"Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients","volume":"270","author":"Port","year":"1993","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.transproceed.2024.03.042_bib0003","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.transproceed.2024.03.042_bib0004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/ajkd.1998.v32.pm9669429","article-title":"Changes in quality of life after renal transplantation","volume":"32","author":"Jofr\u00e9","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.transproceed.2024.03.042_bib0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int."},{"issue":"Suppl. 2","key":"10.1016\/j.transproceed.2024.03.042_bib0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16982","article-title":"OPTN\/SRTR 2020 annual data report: kidney","volume":"22","author":"Lentine","year":"2022","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1016\/j.transproceed.2024.03.042_bib0007","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.transproceed.2024.03.042_bib0008","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.transproceed.2024.03.042_bib0009","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.transproceed.2024.03.042_bib0010","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1097\/TP.0000000000002892","article-title":"Intentional transmission of hepatitis C with organ transplantation: with opportunity comes responsibility","volume":"103","author":"Kahn","year":"2019","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.transproceed.2024.03.042_bib0011","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1681\/ASN.2019050462","article-title":"National trends in utilization and 1-year outcomes with transplantation of HCV-viremic kidneys","volume":"30","author":"Potluri","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.transproceed.2024.03.042_bib0012","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/ajt.15530","article-title":"Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: single center experience","volume":"19","author":"Molnar","year":"2019","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.transproceed.2024.03.042_bib0013","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/ajt.15496","article-title":"Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals","volume":"19","author":"La Hoz","year":"2019","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2024.03.042_bib0014","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ajt.15664","article-title":"Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients","volume":"20","author":"Gupta","year":"2020","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.transproceed.2024.03.042_bib0015","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/ajt.15355","article-title":"Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States","volume":"19","author":"Bowring","year":"2019","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2024.03.042_bib0016","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/TP.0000000000003014","article-title":"Liver and kidney recipient selection of hepatitis C virus viremic donors: meeting consensus report from the 2019 controversies in transplantation","volume":"104","author":"Burton","year":"2020","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.transproceed.2024.03.042_bib0017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MOT.0000000000001031","article-title":"Utilization of hepatitis C virus-positive donors in kidney transplantation","volume":"28","author":"Shetty","year":"2023","journal-title":"Curr Opin Organ Transplant."},{"issue":"1","key":"10.1016\/j.transproceed.2024.03.042_bib0018","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.30933","article-title":"Utilization of hepatitis C virus (HCV)-viremic organs for HCV negative recipients: is practice speeding past the evidence?","volume":"71","author":"Verna","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.transproceed.2024.03.042_bib0019","doi-asserted-by":"crossref","first-page":"e13833","DOI":"10.1111\/ctr.13833","article-title":"Transplantation of viral-positive hepatitis C-positive kidneys into uninfected recipients offers an opportunity to increase organ access","volume":"34","author":"Graham","year":"2020","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2024.03.042_bib0020","doi-asserted-by":"crossref","first-page":"e13540","DOI":"10.1111\/tid.13540","article-title":"Hepatitis C-positive donor to negative recipient kidney transplantation: a real-world experience","volume":"23","author":"Jandovitz","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.transproceed.2024.03.042_bib0021","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ajt.2023.03.001","article-title":"Temporal changes in the utilization of kidneys from hepatitis C virus-infected donors in the United States","volume":"23","author":"Buchanan-Peart","year":"2023","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.transproceed.2024.03.042_bib0022","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.29572","article-title":"The rise of the opioid epidemic and hepatitis C-positive organs: a new era in liver transplantation","volume":"67","author":"Gonzalez","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.transproceed.2024.03.042_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6371","article-title":"Prevalence of hepatitis C virus infection in US States and the District of Columbia, 2013 to 2016","volume":"1","author":"Rosenberg","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.transproceed.2024.03.042_bib0024","first-page":"141","article-title":"Competitive market analysis of transplant centers and discrepancy of wait-listing of recipients for kidney transplantation","volume":"6","author":"Cho","year":"2015","journal-title":"Int J Organ Transplant Med"},{"issue":"12","key":"10.1016\/j.transproceed.2024.03.042_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27551","article-title":"Donor characteristics and regional differences in the utilization of HCV-positive donors in liver transplantation","volume":"3","author":"Da","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.transproceed.2024.03.042_bib0026","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/TP.0000000000003382","article-title":"Liver transplantation of HCV-viremic donors into HCV-negative recipients in the United States: increasing frequency with profound geographic variation","volume":"105","author":"Cotter","year":"2021","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.transproceed.2024.03.042_bib0027","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1111\/ajt.15857","article-title":"Local and regional variability in utilization and allocation of hepatitis C virus-infected hearts for transplantation","volume":"20","author":"Prakash","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2024.03.042_bib0028","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2215\/CJN.10960720","article-title":"Trends in discard of kidneys from hepatitis C viremic donors in the United States","volume":"16","author":"Chang","year":"2021","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524003440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524003440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T05:15:38Z","timestamp":1724822138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524003440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0041134524003440"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.03.042","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}